Resources To Prevent Youth Vaping Act

H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding upcoming proposed rule on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products

Client expense: $570,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Quit Because of COVID-19 Act (H.R. 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/H.R. 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA nicotine product standard

Client expense: $70,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Risk-proporitionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act

Client expense: Not reported · Firm income: $80,000

H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding upcoming proposed rule on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products

Client expense: $620,000 · Firm income: Not reported

Quit Because of COVID-19 Act (H.R. 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/H.R. 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products FDA nicotine product standard

Client expense: $180,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding upcoming proposed rule on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products

Client expense: $680,000 · Firm income: Not reported

Risk-proporitionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use; issues related to enforcement of illicit tobacco products, including importation of counterfeit products; and unregulated nicotine products; issues related to taxation and user fees for tobacco and electronic nicotine delivery system products; issues related to regulation of synthetic nicotine products; discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products; H.R. 2125/H.r. 2185/S. 2622, the Quit Because of COVID-19 Act; H.R. 2786/S.1314, the Tobacco Tax Equity Act of 2021; H.R. 3051, the End ENDS Act of 2021; H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021; H.R. 3407/S.411, the Mothers and Offspring Mortality and Morbidity Awareness Act; H.R. 4629/S. 2445, the Resources to Prevent Youth Vaping Act; H.R. 5546/S. 2974, the PROTECT Act

Client expense: Not reported · Firm income: $80,000

Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043) FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products

Client expense: $220,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Consolidated Appropriations Act, 2022 (Pub.L. 117-103), sections pertaining to FDA authority to regulate synthetic nicotine FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Modified Risk Tobacco Product applications FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043)

Client expense: $200,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding efforts to prevent youth access to tobacco products Discussions regarding federal excise taxes and the taxation of tobacco products

Client expense: $720,000 · Firm income: Not reported

Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Issues related to regulation of synthetic nicotine products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125/H.R. 2185/S. 2622, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021 H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act H.R. 5546/S. 2974, the PROTECT Act H.R. 6286, the Clarifying Authority over Nicotine Act of 2021

Client expense: $580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA regulation of synthetic nicotine FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043)

Client expense: $120,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding efforts to prevent youth access to tobacco products Discussions regarding federal excise taxes and the taxation of tobacco products

Client expense: $750,000 · Firm income: Not reported

Risk-proportionate regulation for electronic nicotine delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of counterfeit products, and unregulated nicotine products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products. H.R. 2125, the Quit Because of COVID-19 Act. H.R. 2786/S. 1314, the Tobacco Tax Equity Act of 2021. H.R. 3051, the End ENDS Act of 2021. H.R. 3226, the Accurate Reporting of Smoking Variants Act of 2021 H.R. 3407/S. 411, the Mothers and Offspring Mortality and Morbidity Awareness Act. H.R. 4629/S. 2445, the Resources To Prevent Youth Vaping Act

Client expense: $590,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA action to remove menthol cigarettes from the market FDA action to remove flavored cigars from the market FDA review of Premarket Tobacco Product Applications FDA oversight of flavored tobacco products Quit Because of COVID-19 Act (HR 2125/S. 2622) Resources to Prevent Youth Vaping Act (S. 2445/HR 4629) Tobacco Tax Equity Act of 2021 (H.R. 2786/S. 1314) To amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes (H.R. 3883/S. 2043)

Client expense: $140,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

H.R. 3051, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act S. 2445/H.R. 4629, Resources to Prevent Youth Vaping Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Application and Modified Risk Tobacco Product compliance policies Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding efforts to prevent youth access to tobacco products Discussions regarding federal excise taxes and the taxation of tobacco products

Client expense: $740,000 · Firm income: Not reported

Legislation: S. 2599 Senate FY 2022 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products) H.R. 4356 House FY 2022 Appropriations for the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Food and Drug Administration and protecting FDAs authority to oversee all tobacco products) S. _____ Senate FY 2022 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Centers for Disease Control and Prevention) H.R. 4502 House FY 2022 Appropriations for the Departments of Labor, Health and Human Services, and Education, and Related Agencies (Lobbying activities related to FY 2022 appropriations for the Centers for Disease Control and Prevention) H.R. 2125/S. 2622 Quit Because of COVID-19 Act H.R. 2786/S. 1314 Tobacco Tax Equity Act of 2021 H.R. 3226 Accurate Reporting of Smoking Variants Act H.R. 4629/S. 2445 Resources to Prevent Youth Vaping Act H.R. 5376 Build Back Better Act (re tobacco tax & tobacco cessation) H.R. 5546/S. 2974 Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act H.R. ____ Reversing the Youth Tobacco Epidemic Act Issues: COVID-19 and tobacco E-cigarette marketing FDA action to address menthol cigarettes and flavored cigars FDA regulation of synthetic nicotine FDA regulation of tobacco products FDA review of e-cigarettes Medicaid and tobacco cessation Tobacco and maternal health Tobacco cessation Tobacco taxes Tobacco's role in health disparaties

Client expense: $158,000 · Firm income: Not reported

Helping Kids Cope Act (H.R. 4944), support all provisions; Childrens Mental Health Infrastructure Act (H.R. 4943), support all provisions; Crime Victims Fund Sustainability and VOCA Fix Act of 2021 (H.R. 1652, S.611), support all provisions. Resources to Prevent Youth Vaping Act (S. 2445), support all provisions

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE